Negotiated lower costs for 10 widely used prescription drugs under Medicare went into effect Thursday, marking the first implementation of price limits authorized by the 2022 Inflation Reduction Act.
President Donald Trump has announced a new milestone in lowering prescription drug prices for Americans, securing “Most Favored Nation” (MFN) agreements with nine additional pharmaceutical companies.
